Dr. Reddy's Laboratories Ltd. - ADR RDY
The previous Dr. Reddy's Laboratories Ltd. - ADR dividend was 48.77c and it went ex 4 months ago and it was paid 4 months ago.
There is typically 1 dividend per year (excluding specials).
|Summary||Previous dividend||Next dividend|
|Ex-div date||28 Jul 2023 (Fri)||–|
|Pay date||11 Aug 2023 (Fri)||–|
Enter the number of Dr. Reddy's Laboratories Ltd. - ADR shares you hold and we'll calculate your dividend payments:
Sign up for Dr. Reddy's Laboratories Ltd. - ADR and we'll email you the dividend information when they declare.
Add Dr. Reddy's Laboratories Ltd. - ADR to receive free notifications when they declare their dividends.
Your account is set up to receive Dr. Reddy's Laboratories Ltd. - ADR notifications.
|Status||Type||Decl. date||Ex-div date||Pay date||Decl. Currency||Forecast amount||Decl. amount||Accuracy|
|Forecast||Final||–||10 Jul 2026||–||USD||Sign up||—|
|Forecast||Final||–||11 Jul 2025||–||USD||Sign up||—|
|Forecast||Final||–||12 Jul 2024||–||USD||Sign up||—|
|Paid||Final||–||28 Jul 2023||11 Aug 2023||USD||—||48.77c|
|Paid||Final||24 May 2022||01 Aug 2022||12 Aug 2022||USD||—||37.84c|
|Paid||Final||16 Jun 2021||08 Jul 2021||11 Aug 2021||USD||—||38.7c|
|Paid||Final||26 Jun 2020||10 Jul 2020||17 Aug 2020||USD||—||33.34c|
|Paid||Final||–||12 Jul 2019||15 Aug 2019||USD||—||28.22c|
|Paid||Final||–||13 Jul 2018||09 Aug 2018||USD||—||29.2c|
|Paid||Final||–||13 Jul 2017||10 Aug 2017||USD||—||31.39c|
|Paid||Final||–||14 Jul 2016||09 Aug 2016||USD||—||29.95c|
|Paid||Final||07 Jul 2015||08 Jul 2015||17 Aug 2015||USD||—||31.29c|
|Paid||Final||05 Jun 2014||01 Aug 2014||15 Aug 2014||USD||—||29.15c|
|Paid||Final||05 Jun 2013||10 Jul 2013||15 Aug 2013||USD||—||26.44c|
|2023||Sign Up Required|
|2024||Sign Up Required|
|2025||Sign Up Required|
Dr. Reddy's Laboratories Ltd. Optimized Dividend Chart
About Dr. Reddy's Laboratories Ltd.
Dr. Reddy's Laboratories Limited is an India-based pharmaceutical company. The Company’s segments include Global Generics, which is engaged in manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics); Pharmaceutical Services and Active Ingredients (PSAI), which is engaged in manufacturing and marketing active pharmaceutical ingredients and intermediates for finished pharmaceutical products; Proprietary Products, which focuses on research and development of differentiated formulations and Others, which consists of the Company’s wholly-owned subsidiary, Aurigene Discovery Technologies Limited, which is a discovery stage biotechnology company developing novel and therapies in the fields of oncology and inflammation.
- Pharmaceuticals & Biotechnology
- United States
- Share Price
- $69.58 (yesterday's closing price)
- Shares in Issue
- 167 million
- Market Cap
- Market Indices